CDNA CLONING, CHROMOSOMAL MAPPING, AND FUNCTIONAL-CHARACTERIZATION OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR

被引:450
作者
SHER, T [1 ]
YI, HF [1 ]
MCBRIDE, OW [1 ]
GONZALEZ, FJ [1 ]
机构
[1] NCI,BIOCHEM LAB,BETHESDA,MD 20892
关键词
D O I
10.1021/bi00072a015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human peroxisome proliferator activated receptor (hPPAR) was cloned from a human liver cDNA library. The cDNA exhibited 85% and 91% DNA and deduced amino acid sequence identity with mouse PPAR (mPPAR), respectively. The hPPAR gene was mapped on human chromosome 22 slightly telomeric to a linkage group of six genes and genetic markers that are located in the general region 22q12q-q13.1. Cotransfection assays of mouse Hepa 1 cells were used to roughly compare the ability of hPPAR- and mPPAR-expressed cDNAs to trans-activate the acyl CoA oxidase (ACO) PPAR response element located 5' upstream to the minimal thymidine kinase promoter driving the expression of the chloramphenicol acetyl transferase (CAT) reporter gene. Both receptors elicited a response with the prototypical peroxisome proliferators nafenopin, clofibrate, and WY-14,643. Moreover, using cotransfection assays in which the CAT reporter plasmid contained the CYP4A6 gene response element rather than the ACO element, it was shown that hPPAR is capable of very efficently trans-activating a second PPAR response element. These results indicate that the PPAR is present in humans in a form that is functional and can trans-activate response elements derived from two different genes, the rat ACO and the rabbit CYP4A6.
引用
收藏
页码:5598 / 5604
页数:7
相关论文
共 40 条
  • [1] Berioli S, 1990, Cardiologia, V35, P335
  • [2] STIMULATION OF DNA-SYNTHESIS BUT NOT OF PEROXISOMAL BETA-OXIDATION BY NAFENOPIN IN PRIMARY CULTURES OF MARMOSET HEPATOCYTES
    BIERI, F
    STAUBLI, W
    WAECHTER, F
    MUAKKASSAHKELLY, S
    BENTLEY, P
    [J]. CELL BIOLOGY INTERNATIONAL REPORTS, 1988, 12 (12) : 1077 - 1087
  • [3] INFLUENCE OF FENOFIBRATE ON CELLULAR AND SUBCELLULAR LIVER STRUCTURE IN HYPERLIPIDEMIC PATIENTS
    BLUMCKE, S
    SCHWARTZKOPFF, W
    LOBECK, H
    EDMONDSON, NA
    PRENTICE, DE
    BLANE, GF
    [J]. ATHEROSCLEROSIS, 1983, 46 (01) : 105 - 116
  • [4] PROGRAM DESCRIPTION - CENTER-DETUDE-DU-POLYMORPHISME-HUMAIN (CEPH) - COLLABORATIVE GENETIC-MAPPING OF THE HUMAN GENOME
    DAUSSET, J
    CANN, H
    COHEN, D
    LATHROP, M
    LALOUEL, JM
    WHITE, R
    [J]. GENOMICS, 1990, 6 (03) : 575 - 577
  • [5] FIREFLY LUCIFERASE GENE - STRUCTURE AND EXPRESSION IN MAMMALIAN-CELLS
    DEWET, JR
    WOOD, KV
    DELUCA, M
    HELINSKI, DR
    SUBRAMANI, S
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (02) : 725 - 737
  • [6] A GENETIC-LINKAGE MAP OF THE HUMAN GENOME
    DONISKELLER, H
    GREEN, P
    HELMS, C
    CARTINHOUR, S
    WEIFFENBACH, B
    STEPHENS, K
    KEITH, TP
    BOWDEN, DW
    SMITH, DR
    LANDER, ES
    BOTSTEIN, D
    AKOTS, G
    REDIKER, KS
    GRAVIUS, T
    BROWN, VA
    RISING, MB
    PARKER, C
    POWERS, JA
    WATT, DE
    KAUFFMAN, ER
    BRICKER, A
    PHIPPS, P
    MULLERKAHLE, H
    FULTON, TR
    NG, S
    SCHUMM, JW
    BRAMAN, JC
    KNOWLTON, RG
    BARKER, DF
    CROOKS, SM
    LINCOLN, SE
    DALY, MJ
    ABRAHAMSON, J
    [J]. CELL, 1987, 51 (02) : 319 - 337
  • [7] CONTROL OF THE PEROXISOMAL BETA-OXIDATION PATHWAY BY A NOVEL FAMILY OF NUCLEAR HORMONE RECEPTORS
    DREYER, C
    KREY, G
    KELLER, H
    GIVEL, F
    HELFTENBEIN, G
    WAHLI, W
    [J]. CELL, 1992, 68 (05) : 879 - 887
  • [8] DUJOVNE CA, 1970, CLIN PHARMACOL THER, V12, P117
  • [9] A MAP OF 22 LOCI ON HUMAN CHROMOSOME-22
    DUMANSKI, JP
    CARLBOM, E
    COLLINS, VP
    NORDENSKJOLD, M
    EMANUEL, BS
    BUDARF, ML
    MCDERMID, HE
    WOLFF, R
    OCONNELL, P
    WHITE, R
    LALOUEL, JM
    LEPPERT, M
    [J]. GENOMICS, 1991, 11 (03) : 709 - 719
  • [10] HEPATIC PEROXISOMAL CHANGES INDUCED BY A TETRAZOLE-SUBSTITUTED ALKOXYACETOPHENONE IN RATS AND COMPARISON WITH OTHER SPECIES
    EACHO, PI
    FOXWORTHY, PS
    JOHNSON, WD
    HOOVER, DM
    WHITE, SL
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1986, 83 (03) : 430 - 437